Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center

Background: A salutary effect of treatments for Gaucher disease (GD) has been a reduction in the incidence of avascular osteonecrosis (AVN). However, there are reports of AVN in patients receiving enzyme replacement therapy (ERT) , and it is not known whether it is related to individual treatments,...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Mohsen Basiri, Mohammad E Ghaffari, Jiapeng Ruan, Vagishwari Murugesan, Nathaniel Kleytman, Glenn Belinsky, Amir Akhavan, Andrew Lischuk, Lilu Guo, Katherine Klinger, Pramod K Mistry
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	eLife Sciences Publications Ltd 2023-05-01
סדרה:	eLife
נושאים:	Gaucher disease avascular osteonecrosis lysosomal disease GBA1 glucosylsphingosine
גישה מקוונת:	https://elifesciences.org/articles/87537
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!